SCHEMBL13517469

SCHEMBL13517469

CC1C(=O)CCC2(C)CCCCC12

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA4 P22748 1/20 0.36
▸ CYP19A1 P11511 6/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MBOAT4 Q96T53 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ SHBG P04278 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23824847 0.78 TRPA1 (0.33) CYP19A1SHBGALDH1A1L3MBTL1
SCHEMBL18806695 0.73 CYP19A1 (0.43) CYP19A1TSHRSHBGALDH1A1
SCHEMBL20277453 0.73 CYP19A1 (0.43) CYP19A1TSHRSHBGALDH1A1
SCHEMBL9243343 0.70 — —
SCHEMBL11950868 0.70 SHBG (0.41) CYP19A1SHBGALDH1A1
SCHEMBL20278150 0.70 SHBG (0.41) CYP19A1SHBGALDH1A1
SCHEMBL13910067 0.70 SHBG (0.41) CYP19A1SHBGALDH1A1
SCHEMBL4227574 0.70 SHBG (0.41) CYP19A1SHBGALDH1A1
SCHEMBL21926361 0.70 SHBG (0.41) CYP19A1SHBGALDH1A1
SCHEMBL5224726 0.70 CYP19A1 (0.31) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2644688-B1 Novel pyrimidine derivatives and their use in perfume compositions INT FLAVORS & FRAGRANCES INC (US) 2017-11-08 — — EP disclosed
EP-2644688-B1 Novel pyrimidine derivatives and their use in perfume compositions INT FLAVORS & FRAGRANCES INC (US) 2017-11-08 — — EP disclosed
EP-2851415-B1 Novel quinazoline derivatives and their use in perfume compositions INT FLAVORS & FRAGRANCES INC (US) 2016-04-27 — — EP disclosed
EP-2851415-B1 Novel quinazoline derivatives and their use in perfume compositions INT FLAVORS & FRAGRANCES INC (US) 2016-04-27 — — EP disclosed
EP-2851415-A1 Novel quinazoline derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2015-03-25 — — EP disclosed
EP-2851415-A1 Novel quinazoline derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2015-03-25 — — EP disclosed
US-8557876-B2 Pyrimidine derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2013-10-15 — — US disclosed
US-8557876-B2 Pyrimidine derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2013-10-15 — — US disclosed
US-8557876-B2 Pyrimidine derivatives and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2013-10-15 — — US disclosed
EP-2644688-A2 Novel pyrimidine derivatives and their use in perfume compositions International Flavors & Fragrances Inc. (US) 2013-10-02 — — EP disclosed
EP-2644688-A2 Novel pyrimidine derivatives and their use in perfume compositions International Flavors & Fragrances Inc. (US) 2013-10-02 — — EP disclosed
US-20120277325-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS INTERNATIONAL FLAVORS & FRAGRANCES INC. 2012-11-01 — — US disclosed
US-20120277325-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS INTERNATIONAL FLAVORS & FRAGRANCES INC. 2012-11-01 — — US disclosed
US-20120277325-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS INTERNATIONAL FLAVORS & FRAGRANCES INC. 2012-11-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277325-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS DPYD, HINT1, MTR CA1 4606/4885CA2 4315/4885CA4 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback